close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar15Point71
Implied share price

Sell Overvalued by 5.3%

5% margin of safety What's this?

EV / EBITDA
Use Average
SSRX
3SBio Inc. (ADR)
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 10.79 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $15.71 $141.23 $169.44 $56.52 $80.16
Market Cap 2,980 130,102 107,921 100,042 98,744
Net Debt -872 47 7,450 -3,369 7,330
Enterprise Value (EV) 1,690 130,149 115,371 96,673 56,725
Revenue 669 21,662 32,639 13,418 34,861
EBITDA 156 10,657 23,287 5,661 11,136
Percent 23.4 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 128 8,530 22,189 5,069 7,186
Percent 19.2 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 1,470 71,449 51,716 21,787 102,321
Total Liabilities 102 43,366 33,182 6,116 44,272
Shareholders Equity 1,367 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.